Indication (Argentina, Canada, Colombia, Hong Kong, Australia, Belarus, Korea, Russia, South Africa)
The AtriCure Bipolar (Transpolar) System is intended to ablate soft tissue during general surgical procedures.
Indication (Brazil, Chile, Costa Rica, Kuwait, New Zealand, Saudi Arabia, Taiwan, UAE, UK)
The AtriCure Bipolar (Transpolar) System is indicated for ablation and coagulation of soft tissue in general, ENT, thoracic, urological, gynecological surgical procedures and ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the Maze procedure for the treatment of cardiac arrhythmias, including atrial fibrillation.
Indication (EU Region and Serbia)
The AtriCure Isolator Synergy Ablation System is indicated for ablation of cardiac tissue for the treatment of cardiac arrhythmias, including atrial fibrillation.
Indication (China, Japan)
The AtriCure Bipolar (Transpolar) System is indicated for the ablation of cardiac tissue.
Indication (Singapore)
The AtriCure Bipolar (Transpolar) System is indicated for ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the treatment of atrial fibrillation.